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THE PROBLEM
Treatment of abdominal aortic aneurysm (AAA) with
minimally invasive techniques has recently gained tremen-
dous national and international attention. However, en-
thusiasm for this new technique has diverted attention from
an equally important issue, that of early detection or screen-
ing for aneurysms. Over the past 20 years, despite advances
in diagnostic imaging and in general medical care of pa-
tients, there has been essentially no change in the number
of patients seen in US hospitals with ruptured AAA.1 Ap-
proximately 15,000 persons die of ruptured AAA and dis-
sections each year.2 However, this may be the tip of the
iceberg. It is estimated that 300,000 persons per year die
suddenly without receiving medical care.3 Furthermore,
studies have shown that the incidence of ruptured AAA in
cases of sudden death ranges from 4% to 5%.4-6 Thus the
yearly death rate from ruptured AAA could be as high as
30,000. This is comparable to a yearly mortality of 32,000
for prostate cancer and 42,000 for breast cancer.2 The
foregoing data strongly emphasize the increasingly recog-
nized7 need for a strategy that will enable early detection of
aneurysms.
COST AND EFFICACY OF SCREENING
When evaluating the cost and effectiveness of screening
programs, four important issues must be considered: cost,
invasiveness, and accuracy of the screening test; prevalence
of the disease; efficacy of interventions to treat the disease;
and cost of these interventions. Screening for AAA can be
performed with a simple noninvasive ultrasound study. It is
well-documented that a limited ultrasound examination is
extremely accurate in identifying the presence of AAA.8
The prevalence of AAA is quite high if selected populations
are screened. For example, the incidence of AAA larger
than 3 cm in all men older than 60 years is 4% to 8%.9-14 If
patients have cardiovascular risk factors, such as smoking,
hypertension, or history of peripheral arterial disease, the
incidence of AAA increases two to five times.15 The preva-
lence of AAA larger than 3 cm in women older than 60
years is only 1.5%.9,16-19 However, in female patients with
a family history of aneurysm or with multiple cardiovascular
risk factors the incidence of AAA is also two to three times
higher than in those without these factors.20 The efficacy of
treatment of large aneurysms is profound. The yearly inci-
dence of rupture and death in patients with AAA larger than
5.5 cm is 16%, compared with periopoerative mortality of
2% to 6% for open repair.1,10,13,14,19,21-24 Moreover, re-
cent data suggest that the mortality rate for endovascular
AAA repair may be as low as 1%.25 Thus patients with large
aneurysms clearly benefit from repair.
As of yet, there is no definitive treatment for “small”
aneurysms, and a screening program will identify many of
these. Nevertheless, rate of growth of small AAAs is rela-
tively predictable. With appropriate surveillance, early iden-
tification of small aneurysms is quite beneficial for those
patients with aneurysms that enlarge and reach treatment
thresholds. In addition, emerging data suggest that medi-
cines such as doxycycline, and risk factor modification may
retard aneurysm expansion.26-29 Early identification of an-
eurysms will enable application of these treatments and
analysis of their efficacy.
Although AAA repair with open or endovascular tech-
niques is expensive, the cost more than doubles if repair is
performed emergently.1 When these various factors were
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incorporated into a Markov decision analysis model, AAA
screening was found to be cost-effective.8 The cost per
quality-adjusted life year saved for screening men older
than 60 years was $11,285. This number compares favor-
ably with the cost-effectiveness of other well-accepted in-
terventions, such as coronary artery bypass grafting
($26,117)30 or hemodialysis ($54,400).31 Of interest, the
cost-effectiveness of AAA screening appears to be similar to
that of screening mammography ($16,000-$20,000).32 As
might be anticipated, AAA screening is not cost-effective in
patients older than 84 years.8
PROSPECTIVE STUDIES
The benefit of screening for AAA has been demon-
strated in six prospective randomized stud-
ies.10,11,13,14,19,21-23 Although these studies were per-
formed in multiple countries, with variable patient cohorts,
the findings are surprisingly similar. Male patients of vari-
ous ages were invited to participate in ultrasound screening,
and subsequently aneurysm-related mortality rates in the
screened and unscreened populations were compared. Pa-
tient response to the request for screening was high (74%-
84%), and follow-up ranged from 4 to 10
years.10,13,14,19,21-23 In screened patients the authors ob-
served a remarkable 45% to 49% reduction in incidence of
ruptured AAA10,13 and a 21% to 68% decrease in aneurysm-
related deaths.10,13,14,19,21 The largest of these studies was
a recently published randomized trial in the United King-
dom that involved 70,495 men ages 65 to 74 years.10
Eighty percent of patients responded to the request for
screening. Mortality associated with elective AAA repair
was 6%. At 4 years the authors found a 42% reduction in
deaths from AAA in the invited group. Moreover, the
mortality curves for screened and unscreened patients in
this trial continue to diverge after 4 years.
CONTROVERSIAL ISSUES
Several concerns have been raised about the utility of
population-based screening for AAA. It has been proposed
that patients who are found to have “small” aneurysms will
experience a diminished quality of life related to concern
about rupture.33-35 Level of anxiety, however, appears to
diminish when a prudent plan of treatment is provid-
ed.35,36 As with any screening program, there will be
patients who do not participate. However, similar screening
programs within and outside the United States enjoy ac-
ceptance rates that range from 75% to 88%.10,14,37,38
Moreover, very little cost is incurred for patients who do
not participate in screening. Aortic aneurysm disease is one
of the least-known killers in American society. Initiation of
an educational program to inform seniors and their physi-
cians of this disease will increase the rate of response to
screening and constitute an important step in a strategy to
prevent death from aneurysm rupture. Last, critics have
suggested that screening may identify a large number of
patients who are unfit for surgery.33 However, Irvine et al23
found that patients identified through screening were
healthier than those in whom aneurysms were discovered
incidentally. Moreover, endovascular techniques will also
likely reduce the percentage of patients who are unfit for
aneurysm repair.
RECOMMENDATIONS
On the basis of available data we recommend baseline
ultrasound screening for AAA in the following patient
cohorts:
● All men aged 60 to 85 years
● Women aged 60 to 85 years with cardiovascular risk
factors
● Men and women older than 50 years with a family history
of AAA.
Patients who appear unfit for any intervention should
not be screened. On the basis of available data we recom-
mend subsequent surveillance of screened patients as fol-
lows:
● Aortic diameter less than 3 cm, no further testing
● AAA 3 to 4 cm in diameter, yearly ultrasound examina-
tion
● AAA 4 to 4.5 cm in diameter, ultrasound examination
every 6 months
● AAA greater than 4.5 cm in diameter, referral to a
vascular specialist.
CONCLUSIONS
There are compelling data that in appropriately selected
patient cohorts identification of AAA can save lives at a cost
to society that compares favorably with other well-accepted
interventions. Inasmuch as reimbursement remains the ma-
jor impediment to acceptance of aneurysm screening, we
strongly encourage that insurers adopt a policy that allows
payment for this life-saving test.
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